<DOC>
	<DOC>NCT02446327</DOC>
	<brief_summary>The main objective is to replicate the validation of omics biomarkers of left ventricular diastolic dysfunction in patients with metabolic syndrome. The aim was to recruit overall 750 patients in Europe (100 for France). Currently, 625 patients were enrolled in Europe and 47 in France.</brief_summary>
	<brief_title>The Metabolic Road to Diastolic Heart Failure: Diastolic Heart Failure Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure, Diastolic</mesh_term>
	<criteria>Patients 18 years of age or older Signs or symptoms of HF Able and willing to provide freely given written informed consent including analysis of genomics Patients with acute myocardial infarction Recent trauma or surgery (&lt; 3 months) Hemodynamically significant valvular disease Serious cerebrovascular disease or stroke in the last 3 months Chronic dialysis Chronic liver disease Chronic infectious (bacterial or viral) disease Any malignant concomitant diseases or a malignant disease in the last 5 years Systemic inflammatory diseases, such as autoimmune diseases, connective tissue diseases or collagenoses Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>